Nephros (NEPH) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$20.7M

Revenue (quarter)

$6.0M

Revenue growth (year over year)

+36.16%

Gross profit (trailing twelve months)

$12.7M

Gross margin

61.26%

Net income (trailing twelve months)

$1.7M

Net income (quarter)

$1.2M

Net income growth (year over year)

+405.06%

Net margin

8.38%

Return on equity

16.10%

EPS (trailing twelve months)

$0.16

Book value per share

$1.10

P/E (trailing twelve months)

21.90

Price to book

3.18

Debt to assets

24.11%

Payout ratio

—

Dividend yield

—

Company profile

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

• Is Nephros (NEPH) profitable?

  Yes. Nephros earned $1.7M in net income over the trailing twelve months, a net margin of 8.38%.

• How much revenue does Nephros (NEPH) make?

  Nephros generated $20.7M in revenue over the trailing twelve months, up 36.16% year over year.

• What is NEPH's P/E ratio?

  Nephros trades at 21.9 times trailing twelve-month earnings, on an EPS of $0.16.

• How do I buy stock in Nephros (NEPH)?

  NEPH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.